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Abstract 
Purpose: To investigate the fate of ciprofloxacin, after concomitant administration with the aqueous leaf 
extract of Carica papaya, which herbal practitioners in Nigeria have found helpful in the treatment of 
painful crisis in sickle cell anaemia (SCA)  patients.  
Method:  Thirteen rabbits were fasted for 12 h and given by oral route 20 mg/kg ciprofloxacin (control 
group); after a 3-week crossover period, the animals were given 500 mg/kg aqueous extract of Carica 
papaya followed by 20 mg/kg ciprofloxacin (treatment group). Blood samples were collected over a 
period of 0 - 24 h post-dosing, and pharmacokinetic profile of ciprofloxacin in plasma sample 
determined using a validated high performance liquid chromatography (HPLC) method. 
Results:  Time to attain maximum plasma ciprofloxacin concentration (Tmax), lag time and clearance 
(CL/F) were higher in the treated group; all other pharmacokinetic parameters showed significant 
decrease in the treated group (p < 0.005) compared to the control group. The slow rate of elimination of 
ciprofloxacin in the control group (0.32 ± 0.11 h-1) compared to the treated group (0.21 ± 0.07 h-1) was 
not due to kidney impairment as plasma creatinine level indicated that kidney function was within normal 
range (0.68 ± 2.78 mg/dl).   
Conclusion:  The results of the study show that there is interaction between ciprofloxacin and Carica 
papaya. This interaction can be avoided by taking ciprofloxacin at least 3 h prior to administration of the 
leaf extract of C. papaya.   
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The use of herbal preparations for medicinal 
purposes is in parallel with conventional drugs in 
some populations. Also, fortification or 
concurrent administration of conventional drugs 
with herbal preparation is on the increase. It is 
known that herbs can affect body functions; 
therefore when taken concurrently with 
conventional drugs, interactions are possible. 
Thus a great concern has arisen on possible 
drug-herb interaction. 
 
Ciprofloxacin is a fluoroquinolone antibiotic with 
excellent activity against gram positive and gram 
negative bacteria as well as Mycobacteria. Oral 
absorption of this drug has been reported to be 
affected by its metal cation complexation (Figure 
1) which has been extensively studied for 
antacids [1-3] mineral supplement [4] and milk 
products [5,6]. However, literature on its 
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interaction with ciprofloxacin is lacking. 
Ciprofloxacin is well prescribed for the treatment 
of infections associated with sickle cell anaemia 
(SCA): a hereditary blood disorder caused by a 
single amino acid substitution [GluVal] at the 
sixth position of the β-chain haemoglobin.  
Similarly, herbal preparation of the leaf of Carica 
papaya is in good use, traditionally for the relief 
of painful crisis associated with SCA in Nigeria. 
 
Carica papaya L., (Caricaceae) which is widely 
cultivated for its edible melon-like fruit is 
available throughout the year [7]. Phytochemical 
studies show C. papaya to contain vitamin C, 
vitamin E, pectin, carotinoids, alkaloids, carpain, 
nicotine, flavonols, tannins, terpinenes, enzymes 
papain and chymopapain [8,9]. These enzymes 
are similar to pepsin and help to digest protein in 
the body, used to relief indigestion, dyspepsia, 
reducing enlarged tonsils [9]. Flowers of C. 
papaya are used in the treatment of jaundice 
[personal communication] and inner bark used 
for sore throat [10]. The extract of unripe fruit and 
dried leaves of C. papaya have been reported to 
possess antisickling properties, thus used as an 
antisickling agent in the management of SCA in 
Western Nigeria [10,11]. 
 
The frequent use of ciprofloxacin and C.  papaya 
in the management of SCA in Western Nigeria 
with no literature on their possible interaction 
prompted our study. We therefore investigated 




Figure 1:  Structure of ciprofloxacin (A) and 






The leaves of Carica papaya were collected from 
a farm in Lagos, Nigeria in August, 2012 and 
identified by Mr. Usang Felix of the Forestry 
Research Institute of Nigeria (FRIN) where a 
voucher specimen (FHI: 106994) has been 
deposited. The leaves were dried at room 
temperature and ground into powder. The 
powdered leaf, 500 g was extracted by 
exhaustive Soxhlet extraction into water for 24 h 
(pH 6.4). The aqueous crude extract was freeze 
dried to obtain a weight of 237.15 g (47.43 
%w/w). The crude extract residue was stored at 




Thirteen rabbits weighing between 1.8 and 2.2 kg 
were obtained from an open market and housed 
in a well-ventilated Laboratory Animal Centre of 
the College of Medicine of the University of 
Lagos, Nigeria under standard laboratory 
condition (12:12 h dark/light cycle). This  study  
was  approved  by  the  Health Research  and  
Ethics  Committee  (HREC) of  the  College of 
Medicine of the University  of Lagos, Nigeria 
(CM/HREC/PHM/09/16/014). 
 
The animals were cared for and used in 
accordance with the Institute of Laboratory 
Animal Research (ILAR) guidelines for care and 
use of animals in experimental studies [12]. The 
animals were allowed to acclimatize for 21 days 
during which they had free access to commercial 
pellet diet (Pfizer Feeds, Ibadan, Nigeria, Plc.) 
and water ad libitium.        
 
Chemical reagents  
 
All reagents were of analytical grade from Sigma 
Chemical Co. (St Louis, MO) unless otherwise 
stated. Ciprofloxacin hydrochloride reference 
standard was a gift from Swiss pharma Nigeria. 
Ciprofloxacin tablets (Ciprogem®) were purchase 
from a pharmaceutical shop in Lagos metropolis. 
De-ionized distilled water was used throughout 
the study. Tinidazole, potassium dihydrogen 
phosphate, tetrabutylammonium hydroxide, nitric 
acid, hydrochloric acid were from the British Drug 
House (BDH), Poole, England. 
 
HPLC instrumentation and chromatographic 
conditions 
 
The HPLC System was (Agilent 1100 series 
pump (Serial No DE 43630403, Product No 
G1311A, Hewlett Packard, Germany) equipped 
with Rheodyne 7725i injector (USA) coupled to 
UV detector (Serial No JP43826101 product No 
G1314A, Japan). The degasser (Serial No 
JP40720373, Product No G1379A, Japan) was 
used to remove possible gas in the mobile 
phase. The chromatographic responses were 
recorded by Agilent ChemStation Software 
(Agilent technologies, USA) running on Compaq 
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compatible personal computer (Hewlett Packard) 
with an Inlet Pentium processor operating at 
2799 MHz under Microsoft window operating 
environment and a pin writer hp DeskJet 5652 
printer. The chromatographic separation was 
performed at column temperature of 25 o C on an 
inert silica C18 zorbax SB column, 5 µm particle 
size, 250 mm x 4.6 mm i. d. protected by a 
Lichrospher Si 60 guard column 30 mm x 4.6 mm 
i.d., which was placed between the injector and 
the analytical column. The pH meter was Thermo 
Orion, model 420A (serial No. 071838, Beverly, 
MA, USA). 
 
The mobile phase consisted of pH 3.5 phosphate 
buffer (2 mM): acetonitrile (60:40 v/v) distributed 
by the gradient pump at a flow rate of 1.0 ml/min 
and the effluent monitored by the ultraviolet 
detector at 278 nm. The phosphate buffer was 
prepared fresh each day of the experiment and 
consisted of potassium dihydrogen phosphate, 
tetrabutylammonium hydroxide and phosphoric 
acid in water. 
 
Atomic absorption spectrophotometer 
operating conditions  
 
The composition of  metals in the leaves of C. 
papaya were analyzed using atomic absorption 
spectrophotometer (Buck Scientific, Model 
210VGP AAS, USA) equipped with deuterium 
background corrector and air-acetylene flame 
atomizer. The instrument was optimized by 
altering the wavelength, slit width, lamp current 
and sample energy for each metal to give 
maximum signal strength (Table 1). The 
spectrophotometer was calibrated using 100 and 
1000 µg/l of zinc working standards prepared in 
de-ionized water. Calibration curves of 
absorbance values versus concentration for each 
metal were constructed from different 
concentration (0 to 3000 µg/l) of freshly prepared 
specific metal in de-ionized water. Except for Na 
and K that were determined by emission mode, 
all other metals were determined by absorption 
mode. 
 
Measurement of mineral cation content of 
Carica papaya 
 
The apparatus used for this study were 
thoroughly washed and rinsed with de-ionized 
water. They were thereafter soaked in 10 % 
HNO3 for 24 h and again rinsed severally with 
de-ionized water and kept to dry in a dust free 
room. The determination of the metals in the 
leaves of C. papaya followed a standard 
procedure as described by [13]. Briefly, 2 g of 
powered leaves of C. papaya was sieved and 
subjected to dry ash in a clean porcelain crucible 
in a muffle furnace at 550 °C. The resultant dull 
grey ash was dissolved in 5 ml of HNO3/HCl/H2O 
(1:2:3 v/v/v) and heated gently until brown fumes 
disappeared. To the ash mixture was added 5 ml 
of de-ionized water; heated and the colourless 
solution which was filtered into a 100 ml flask 
using ashless Whatman filter paper was used for 
elemental analysis. The concentration of each 
element in the sample was estimated using their 
respective standard curve and calculated as mg 
metal per 100 g of the plant material. 
 
Drug dosing and sample collection 
 
The rabbits were fasted for 12 h prior to the 
study. On the day of the study, each animal was 
given 20 mg/kg body weight of ciprofloxacin 
(Ciprogem, Gemini Pharmaceutical, Lagos, 
Nigeria) by gastric probe. Whole blood, 5 ml, was 
withdrawn from the retro orbital plexus of each 
animal before (0 hr) and at 0.25, 0.5, 1, 2, 3, 4, 6, 
8, 10, 12 and 24 h post dosing into heparinized 
bottles and centrifuged immediately at 3000 g for 
15 min. 
 















limit  (mg/l) 
Ca 422.7 0.7 4.0 3.912 0.010 
Cu 324.7 0.7 2.0 3.938 0.005 
Cr 357.9 0.7 2.5 3.567 0.050 
Fe 248.3 0.2 15 3.436 0.050 
K 766.5 0.7 2.0 - 0.010 
Mg 285.2 0.7 2.5 3.717 0.003 
Mn 279.5 0.2 3.0 3.937 0.050 
Na 589.0 0.2 5.0 - 0.050 
Pb  283.3 0.7 3.5 2.874 0.030 
Zn 213.9 0.7 3.0 3.237 0.005 
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The plasma was carefully collected using 
Pasteur pipette and stored frozen at -80 C until 
assayed. In another study, after a three week 
washout period, the rabbits were dosed orally 
with aqueous leaf extract of Carica papaya, 500 
mg/kg body weight followed 30 min after with 
ciprofloxacin, 20 mg/kg body weight.  Blood 
samples were withdrawn and treated as in the 
first procedure. Plasma creatinine was also 
estimated by the method of Perrone et al [14] to 
eliminate possible interference of kidney function 






Drug-free plasma was spiked with ciprofloxacin 
standard solution to obtain 2, 4, 6, 8 and 10 
g/ml with each concentration containing 10 
g/ml tinidazole as the internal standard. The 
peak area ratio of ciprofloxacin to tinidazole, was 
plotted against the corresponding concentration 
of ciprofloxacin and a linear regression 
calculated. The calibration study was conducted 
in 10 replicates. 
 
Precision and accuracy 
 
Method validation was performed using the 
frozen drug-free plasma sample with 
ciprofloxacin, 2 to 10 g/ml. Accuracy, assessed 
by recovery efficiency (n=10) was determined by 
comparing the peak area ratio of the spiked 
plasma with the peak area ratio obtained by 
direct injection of the standard solutions of the 
same concentration.  
 
The intra and inter day assays for precision and 
accuracy were obtained in 10 replicate assays at 
varying concentrations of 2 to 10 g/ml. The 
relative standard deviation (RSD) was used for 
the assessment of accuracy and precision. 
Working standard solutions were made fresh 
each day of the assay. 
 
Assay of ciprofloxacin 
 
The concentration of ciprofloxacin in plasma was 
determined in 10 replicates by a validated HPLC 
method [15], with slight modifications. One 
hundred µl of tinidazole (IS, 10 g/ml) was added 
to 0.5 ml plasma followed by acetonitrile, 1 ml, to 
precipitate protein. The mixture was centrifuged 
at 3,000 g for 15 min and 20 µl of the 
supernatant was injected into the HPLC system 
for chromatographic separation. The 
concentration of ciprofloxacin was estimated 
from the calibration curve using calibration 
equation of y = mx + C. 
Pharmacokinetic analysis of data 
 
The plasma concentration time data was 
obtained by a one compartmental analysis. The 
systemic exposure (area under the curve; AUC) 
was estimated by the trapezoidal rule method for 
observed values and this was extrapolated to 
infinity (AUCo→∞). The pharmacokinetic 
parameters, which comprised of time to peak 
plasma concentration (Tmax), peak plasma 
concentration (Cmax), volume of distribution (Vd), 
elimination half life (t1/2), clearance (CL) were 




Data are expressed as mean ± SD (standard 
deviation). Statistical difference among groups 
was assessed by the unpaired Student t- test 





Assessment of metal ion content in Carica 
papaya 
 
The determination of the metal content in the 
leaves of Carica papaya (Table 2) revealed the 
presence of Ca, Cu, Fe, K, Mg, Mn, Na and Zn. 
The toxic heavy metals - lead and chromium 
were below the detection limit. The low levels of 
the toxic heavy metals might be an evident of 
lack of soil contamination of the plantation sites 
of the Carica papaya. 
 




Ca 1134.50 ± 17.93 
Cu 4.51 ± 10.71 
Fe 363.74 ± 25.09 
K 1404.70 ± 11.09 
Mg 401.67 ± 10.41 
Mn 5.73 ± 12.63 
Na 142.87 ± 35.17 
Zn 5.27 ± 17.03 
Pb  Not detected 
Cr Not detected 




The calibration curve was linear with a 
correlation coefficient, r2 of 0.9997 and a 
regression equation of Y = 0.0170X + 0.0019 (X 
= concentration of ciprofloxacin and Y = peak 
area ratio of ciprofloxacin. For the intra or inter 
day assays (n = 10 each), RSD were less than 5 
% in each concentration (Table 3), this shows 
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precision to be good within the range of 
concentrations studied. Accuracy expressed as 
percentage bias was – 4.32 or – 5.25 % for the 
intra and inter day assayed (10 µg/ml; n = 10). 
Accuracy was also assessed from the percent 
recovery of ciprofloxacin that had been added to 
plasma. Mean recovery for intra-day assay was 
97.15 ± 0.15 and 99.77 ± 0.57 % for the 2 and 10 
µg/ml, respectively. The ciprofloxacin solutions in 
plasma stored frozen at – 20 oC was stable over 
the period of experimental analysis. Repeated 
freezing and thawing of the plasma had no effect 
on the concentration of ciprofloxacin. 
 
Pharmacokinetics of ciprofloxacin:  effect of 
Carica papaya co-administration  
 
The mean plasma concentration-time curves of 
the oral administration of ciprofloxacin, 20 mg/kg 
body weight in the control group and the group 
with concomitant administration of C. papaya, 
500 mg/kg body weight are shown in (Figure 2). 
The pharmacokinetic parameters are 
summarized in (Table 4); absorption of 
ciprofloxacin was more rapid in the control group 
than in the group that consumed C. Papaya, 
which was evident by ciprofloxacin appearing in 
the plasma of the control group 10 min earlier 
than in the test group. Cmax was significantly 
higher (p < 0.005) in the control group (3.45 ± 
0.34 mg/L) compared to the treated group (1.71 
± 0.41 mg/L) indicating a 50 % reduction in its 
maximum concentration. The corresponding Tmax 
was found to be longer by 13 % in the treated 
group than in the control with values of 2.02 ± 
0.45 and 1.79 ± 0.33 h respectively. Cmax was 
followed by a concentration decay that could be 
fitted to a straight line on semi logarithmic scale, 
indicating first order mode of elimination. 
Elimination half-life (t½el) was 3.25 ± 0.31 and 
2.20 ± 0.11 h for control and treated groups 
respectively being slower by 32 % in the treated 
group (p < 0.05). The significant high plasma 
concentration of ciprofloxacin resulted in 
significant (p < 0.05) increase in AUC in the 
control group compared to the treated. There 
apparent volume of distribution (Vd/F) was higher 
in the control group compared to the treated. 
Total clearance (CL/F) was found to be 0.13 ± 
0.06 L/h/kg and 0.83 ± 0.10 L/h/kg for control and 
treated groups respectively. 
 












Intra-day      
2 1.94 ± 0.07 3.61 -3.10 97.15 ± 0.15 
4 3.83 ± 0.14 3.66 -4.32 95.75 ± 0.57 
6 5.88 ± 0.23 3.91 -2.31 98.93 ± 0.45 
8 7.79 ± 0.31 3.98 -2.78 97.74 ± 0.72 
10 9.92 ± 0.45 4.51 -0.83 99.77 ± 0.57 
Inter-day      
2 1.98 ± 0.09 4.55 -1.00 99.37 ± 0.33 
4 3.79 ± 0.11 2.90 -5.25 94.87 ± 0.17 
6 5.93 ± 0.24 4.05 -1.17 98.52 ± 0.32 
8 7.94 ± 0.19 2.39 -0.75 99.42 ± 0.24 
10 9.86 ± 0.23 2.33 -1.40 98.68 ± 0.61 
Values are expressed as mean  SD (n = 10); a % RSD = SD/mean x 100; b % accuracy = {(found conc. – 
nominal conc.)/nominal conc.}100 
 
Table 4:  Pharmacokinetic parameters of ciprofloxacin after a single 20 mg/ke oral dose with or without aqueous 




Mean ± SD 
Ciprofloxacin Ciprofloxacin + C. papaya P-value 
Absorption    
Cmax (mg/L) 3.45 ± 0.34 1.71 ± 0.41** < 0.05. 
Tmax   (h) 1.79 ± 0.24 2.02 ± 0.39  
Lag time (h) 0.25 0.45  
Elimination    
T½el  (h) 3.25 ± 0.31 2.20 ± 0.31* < 0.005 
Kel (h-1) 0.32 ± 0.11 0.21 ± 0.07  
F 0.8614 0.3275  
AUC0 - ∞  (mg h/L) 23.6 ±  1.73 11.8 ± 2.21  
Vd/F   (L/kg) 2.41 ± 0.11 1.26 ± 0.20  
CL/F  (L/h/kg) 0.13 ± 0.06 0.83 ± 0.104  
Values are mean ± SD (n = 7); * p < 0.005; **p < 0.05 
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Figure 2:  Mean plasma concentration-time curve of the oral administration of ciprofloxacin (20 





In recent times, high consumption of herbal 
remedies has increased the possibility of 
interaction between conventional drugs and 
natural products. The mixing of herbal remedies 
and prescription drugs could be harmful to 
health, they can alter the way the body 
metabolizes drugs, cancel the effect of drugs, 
increase or decrease the amount of drug in the 
blood stream or its impact to the body. An 
increase in a drug dosage could occur when an 
herb component enhances absorption of a drug, 
or inhibits the enzymes that break down drugs in 
preparation for elimination. Similarly, a decrease 
in the amount of drug could occur by herb 
components binding up the drug and preventing 
it from getting into the blood stream or by 
stimulating the production and activity of 
enzymes that degrades the drugs. 
 
Our study investigated for the first time the 
possible interaction of Carica papaya on the 
absorption and pharmacokinetics of ciprofloxacin 
after concomitant administration. Ciprofloxacin is 
usually well absorbed but in the presence of 
agents containing some cations, its absorption is 
impaired [4,17,18]. The leaf of C. Papaya, as 
demonstrated in this study, contains some 
cations like Mg, Ca, Na, K, Fe, Cu, Zn and Mn 
(Table 2); and is line with the work of [19-21]; 
with this, the result of our pharmacokinetic study 
was not unexpected. When ciprofloxacin was co-
administered with C. papaya, the peak plasma 
concentration (Cmax) significantly decreased by 
50 % with an increase in time to achieve the 
peak plasma concentration, Tmax (p ≤ 0.05, 
Figure 2). Similar result was obtained from the 
study of [4] with co-administration of norfloxacin, 
ofloxacin and ciprofloxacin with 100 mg of 
elemental iron. The faster a drug is absorbed, the 
greater the peak plasma concentration and 
shorter the time to peak plasma concentration 
[22]. It may therefore imply from our study, that 
the reduction in Cmax and longer Tmax may have 
been as a result of reduced rate of absorption in 
the presence of C. papaya which is be supported 
by the 3 fold increased in lag time observed in 
this study.  
 
The elimination half-life of ciprofloxacin following 
co-administration with C. papaya was lower than 
the control. It is known that a drug with a short 
elimination half-life will be eliminated from the 
body much more quickly than a drug with longer 
half-life [22], the results of our study is therefore 
consistent with increased drug elimination, which 
may be evident by large drug clearance and 
reduced apparent volume of distribution in the 
treated group. The slow rate of elimination of 
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ciprofloxacin in the control group (0.32 ± 0.11 h-1) 
compared to the treated (0.21 ± 0.07 h-1) was not 
due to kidney impairment as the plasma 
creatinine level that indicate kidney function was 
within normal range (0.68 ± 2.78 mg/dl). There 
was reduction in the bioavailability of 
ciprofloxacin in the treated group compared to 
the control (p < 0.05). Reduced bioavailability in 
our study is supported by reduced rate of 
absorption and increased rate of elimination. The 
volume of distribution, Vd was reduced 2-fold 
with co-administration of C. papaya, implying 
reduced distribution of ciprofloxacin in this group 
of animals. This may be attributed to reduced 
rate of absorption or low lipophilicity leading to 
poor membrane permeability through the gut 
wall. 
 
There are convincing reports that the impairment 
of the absorption of ciprofloxacin by metal 
cations is as a result of the formation of a water 
soluble, non-absorbable metal chelate complex 
with the 3-carboxyl and 4 keto oxygen groups of 
the ciprofloxacin molecule which are in close 
proximity [23,24] thus resulting in very low 
lipophilicity leading to poor permeation through 
the gut wall [1,6,17]. The presence of cations in 
the leaves of C. papaya may be sufficient in 
impairing the absorption of ciprofloxacin. Each 
cation in the leaf extract may result in the 
formation of ciprofloxacin-metal chelate complex, 
thus increasing the molecular size and bulkiness 
of the drug or form a chemical reaction that can 
lead to poor drug permeation through the gut 
wall. It is also presumed from the study that the 
formation of a ciprofloxacin-metal chelate 
complex is probably the cause of the reduction in 





Taken together, the findings of this study show 
that there is interaction between the extract of C. 
papaya and ciprofloxacin based on 
pharmacokinetic data. This interaction can be 
avoided by taking the ciprofloxacin at least 3 h 
prior to the administration of the leaf extract of C. 
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